Artelo BiosciencesARTL
13F holders, Q1 2026 (March 31)1holders −9
1new positions
9sold out
$544.65avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Artelo Biosciences Inc. (ARTL) in their 13F filings, down 9 from Q4 2025. 1 opened new positions and 9 sold out. The largest holder was Altshuler Shaham Ltd ($484K).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G607
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $484K |
| Exits | 9 | $103K |
All 13F filers, Q4 2025 → Q1 2026: 889 shares bought and 84,477 shares sold, net −83,588 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Altshuler Shaham Ltd | 0.01% | New | 889 | $484K |
"% of holder's portfolio" is ARTL's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.